HANALL BIOPHARMA CO.,LTD
KOSPI
Shareholding pattern
As reported to FSS/DART, 2025-12-31.
| Largest shareholder group | 31.20% |
|---|---|
| Minority shareholders | 54.12% |
| Top 10 holders | 31.10% |
| Total shareholders | 58,309 |
Who owns the company
Share of shares outstandingMinority shareholders 54.12%Largest shareholder & related parties 31.2%Institutions & other holders 14.68%
How to read this: the largest shareholder group is the controlling owner and related parties — a big slice means tight control. Minority shareholders are the many small holders. The remainder is mostly institutional and foreign money, which the regulator does not itemise separately.
Ownership detail
| Investor category | Holding % | Shareholders |
|---|---|---|
| Minority shareholders | 54.12% | 58,299 |
| Largest shareholder & related parties | 31.20% | — |
| Institutions & other holders | 14.68% | — |
How to read this: a high foreign or institutional share often means the stock is widely researched and more liquid; a high individual share means retail investors hold most of the company. Percentages are of voting units.
Largest shareholders
| S.No. | Shareholder | Shares | Stake % |
|---|---|---|---|
| 1 | (주)대웅제약 | 16,115,745 | 30.80% |
| 2 | 박승국 | 176,947 | 0.30% |
| 3 | 정승원 | 24,380 | 0.00% |
| 4 | 박수진 | 1,880 | 0.00% |
Trust banks such as Master Trust and Custody Bank appear at the top of most Japanese registers: they hold shares on behalf of many underlying funds rather than owning them outright.